AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
96 hedge funds and large institutions have $1.03B invested in Aegerion Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
21% less call options, than puts
Call options by funds: $4.27M | Put options by funds: $5.39M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
96
Holding in Top 10
2
Calls
$4.27M
Puts
$5.39M
Top Buyers
| 1 | +$97.7M | |
| 2 | +$11M | |
| 3 | +$7.05M | |
| 4 |
Morgan Stanley
New York
|
+$4.94M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$3.74M |
Top Sellers
| 1 | -$7.24M | |
| 2 | -$3.89M | |
| 3 | -$3.76M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$3.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.27M |